| Net income | 202.83M |
| Provision for credit losses on loans and leases, excluding covered loans | |
| Provision for losses on covered loans | |
| Amortization of intangibles | 3.84M |
| Depreciation and amortization | 33.97M |
| Share-based employee compensation expense | 15.94M |
| Deferred income tax benefit | -7.86M |
| (Gain) loss on disposal of assets | |
| Gain on sale of securities | -5.33M |
| Gain on acquisition | |
| Impairment loss on securities | 337K |
| Other, net | 27.57M |
| Trading securities | 18.37M |
| Other assets and other liabilities, net | -18.19M |
| Net cash provided by operating activities | |
| Purchase of securities available-for-sale | -1.92B |
| Sales of securities available-for-sale | 401.53M |
| Maturities and paydowns of securities available-for-sale | 2.1B |
| Loan originations, net of principal collections | |
| Net payments for premises and equipment | -38.3M |
| Net cash acquired in acquisitions | |
| Other investing activities, net | -2.22M |
| Net cash (used in) provided by investing activities | |
| Net increase in deposits | 3.07B |
| Net decrease in federal funds purchased and securities sold under repurchase agreements | |
| Net decrease in short-term borrowings, net of transfers from long-term debt | |
| Net decrease in long-term debt | |
| Proceeds from exercise of stock options | 30.74M |
| Tax benefit from exercise of stock options | 5.77M |
| Redemption of preferred stock | |
| Repurchase of common stock warrants | |
| Cash dividends paid | -70.65M |
| Other financing activities, net | -6.91M |
| Net cash provided by (used in) financing activities | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of year | 656.45M |
| Cash and cash equivalents at end of period | 2.06B |
| Interest | 40.09M |
| Income taxes | 63.2M |
| Transfer of loans to other real estate owned | |
| Securities available-for-sale | |
| Covered loans | |
| Covered other real estate owned | |
| Deposits | |
| Other borrowings | |